- Home
- MTSR vs SOC Comparison
MTSR vs SOC Comparison
Compare MTSR & SOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTSR
- SOC
- Stock Information
- Founded
- MTSR 2022
- SOC 2020
- Country
- MTSR United States
- SOC United States
- Employees
- MTSR N/A
- SOC N/A
- Industry
- MTSR
- SOC
- Sector
- MTSR
- SOC
- Exchange
- MTSR NYSE
- SOC Nasdaq
- Market Cap
- MTSR 3.0B
- SOC 3.0B
- IPO Year
- MTSR 2025
- SOC N/A
- Fundamental
- Price
- MTSR $27.09
- SOC $21.89
- Analyst Decision
- MTSR Strong Buy
- SOC Buy
- Analyst Count
- MTSR 6
- SOC 4
- Target Price
- MTSR $55.25
- SOC $30.50
- AVG Volume (30 Days)
- MTSR 1.0M
- SOC 2.7M
- Earning Date
- MTSR 08-26-2025
- SOC 08-12-2025
- Dividend Yield
- MTSR N/A
- SOC N/A
- EPS Growth
- MTSR N/A
- SOC N/A
- EPS
- MTSR N/A
- SOC N/A
- Revenue
- MTSR N/A
- SOC N/A
- Revenue This Year
- MTSR N/A
- SOC N/A
- Revenue Next Year
- MTSR N/A
- SOC N/A
- P/E Ratio
- MTSR N/A
- SOC N/A
- Revenue Growth
- MTSR N/A
- SOC N/A
- 52 Week Low
- MTSR $12.30
- SOC $13.66
- 52 Week High
- MTSR $37.99
- SOC $35.00
- Technical
- Relative Strength Index (RSI)
- MTSR N/A
- SOC 39.76
- Support Level
- MTSR N/A
- SOC $21.65
- Resistance Level
- MTSR N/A
- SOC $22.98
- Average True Range (ATR)
- MTSR 0.00
- SOC 1.08
- MACD
- MTSR 0.00
- SOC -0.09
- Stochastic Oscillator
- MTSR 0.00
- SOC 31.37
About MTSR METSERA INC
Metsera Inc is a clinical-stage biotechnology company developing next-generation injectable and oral nutrient-stimulated hormone (NuSH) analog peptides to treat obesity, overweight, and related conditions. The Company has developed and is implementing proprietary methods and platform technologies to advance a broad, scalable, and combinable portfolio of injectable and oral NuSH analog peptides with the potential to address not only the limitations of approved therapies but also many of the anticipated limitations of next-generation therapies in development. The Company uses its proprietary MINT peptide library of NuSH analog peptides alongside its Half-life Augmentation by Lipid Optimization half-life extending platform.
About SOC Sable Offshore Corp. Common Stock
Sable Offshore Corp is a Houston-based independent upstream company focused on responsibly developing the prolific Santa Ynez Unit in federal waters offshore California. The company is managed as one reportable segment, oil and gas.